Brawn Biotech Ltd vs Oxygenta Pharmaceutical Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Brawn Biotech Ltd is ₹ 20.8 as of 04 May 15:30 . The P/E Ratio of Brawn Biotech Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Oxygenta Pharmaceutical Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Brawn Biotech Ltd changed from ₹ 6.63 crore on March 2021 to ₹ 4.88 crore on March 2025 . This represents a CAGR of -5.95% over 5 yearsThe Market Cap of Oxygenta Pharmaceutical Ltd changed from ₹ 34.15 crore on March 2022 to ₹ 294.24 crore on March 2025 . This represents a CAGR of 71.33% over 4 years The revenue of Brawn Biotech Ltd for the Dec '25 is ₹ 4.4 crore as compare to the Sep '25 revenue of ₹ 4.98 crore. This represent the decline of -11.65% The revenue of Oxygenta Pharmaceutical Ltd for the Dec '25 is ₹ 33.93 crore as compare to the Sep '25 revenue of ₹ 14.25 crore. This represent the growth of 138.11% The ebitda of Brawn Biotech Ltd for the Dec '25 is ₹ 0.08 crore as compare to the Sep '25 ebitda of ₹ 0.1 crore. This represent the decline of -20% The ebitda of Oxygenta Pharmaceutical Ltd for the Dec '25 is ₹ -4.08 crore as compare to the Sep '25 ebitda of ₹ -4.63 crore. This represent the decline of -11.88% The net profit of Brawn Biotech Ltd changed from ₹ -0.53 crore to ₹ 0.05 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Oxygenta Pharmaceutical Ltd changed from ₹ -1.36 crore to ₹ -4.84 crore over 7 quarters. This represents a CAGR of 106.55% The Dividend Payout of Brawn Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Oxygenta Pharmaceutical Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Brawn Biotech Ltd

Brawn Biotech Limited was originally incorporated in the name of Brawn Pharmaceuticals Limited in November, 1985.
Thereafter, the name of the Company was changed from Brawn Pharmaceuticals Limited to Brawn Biotech Limited in November, 2010.
Brawn, with its inception barely 38 years back has today evolved into a fully integrated, healthcare group, marking its presence in India and across the globe. The Company possess product registration with major health and govt. institutions throughout India and worldwide.
Headed and represented by a team of skilled industry experts with impressive educational backgrounds and broad experience, the Company has spread its wings in expansion in the domestic as well as in the international markets beyond the existing horizon to stand among the leading Indian HealthCare products distribution Companies.

About Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical Limited was initially incorporated as S S Organics Private Limited as a private limited Company in 1990.
The Company converted its status to a Public Limited Company in 1993 changing the name to S S Organics Limited.
Further, it was changed to Oxygenta Pharmaceutical Limited in FY 2021-22. The Company was incorporated with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals.
It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs.
The Company has plant located at Medak in Andhra Pradesh. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs.

FAQs for the comparison of Brawn Biotech Ltd and Oxygenta Pharmaceutical Ltd

Which company has a larger market capitalization, Brawn Biotech Ltd or Oxygenta Pharmaceutical Ltd?

Market cap of Brawn Biotech Ltd is 5 Cr while Market cap of Oxygenta Pharmaceutical Ltd is 204 Cr

What are the key factors driving the stock performance of Brawn Biotech Ltd and Oxygenta Pharmaceutical Ltd?

The stock performance of Brawn Biotech Ltd and Oxygenta Pharmaceutical Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Brawn Biotech Ltd and Oxygenta Pharmaceutical Ltd?

As of May 5, 2026, the Brawn Biotech Ltd stock price is INR ₹19.0. On the other hand, Oxygenta Pharmaceutical Ltd stock price is INR ₹55.21.

How do dividend payouts of Brawn Biotech Ltd and Oxygenta Pharmaceutical Ltd compare?

To compare the dividend payouts of Brawn Biotech Ltd and Oxygenta Pharmaceutical Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.